Diffusion weighted and dynamic contrast enhanced MRI as an imaging biomarker for stereotactic ablative body radiotherapy (SABR) of primary renal cell carcinoma

about

Diffusion weighted and dynamic contrast enhanced MRI as an imaging biomarker for stereotactic ablative body radiotherapy (SABR) of primary renal cell carcinoma

Item

http://www.wikidata.org/entity/Q58774971

description

article publié dans la revue scientifique PLoS ONE

@fr

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published in PLoS ONE

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Diffusion weighted and dynamic ...... f primary renal cell carcinoma

@en

Diffusion weighted and dynamic ...... tic ablative body radiotherapy

@nl

type

Item

label

Diffusion weighted and dynamic ...... f primary renal cell carcinoma

@en

Diffusion weighted and dynamic ...... tic ablative body radiotherapy

@nl

prefLabel

Diffusion weighted and dynamic ...... f primary renal cell carcinoma

@en

Diffusion weighted and dynamic ...... tic ablative body radiotherapy

@nl

P1476

Diffusion weighted and dynamic ...... f primary renal cell carcinoma

@en

P2093

Bimal K Parameswaran

http://www.w3.org/2001/XMLSchema#string

Diana Roettger

http://www.w3.org/2001/XMLSchema#string

Mark Shaw

http://www.w3.org/2001/XMLSchema#string

Mary E Finnegan

http://www.w3.org/2001/XMLSchema#string

Sarat Chander

http://www.w3.org/2001/XMLSchema#string

Shankar Siva

http://www.w3.org/2001/XMLSchema#string

Tomas Kron

http://www.w3.org/2001/XMLSchema#string

P2860

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

3D Slicer as an image computing platform for the Quantitative Imaging Network

Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths.

Clinical Intravoxel Incoherent Motion and Diffusion MR Imaging: Past, Present, and Future.

Magnetic resonance imaging as a biomarker in renal cell carcinoma.

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Evaluation of treatment response and resistance in metastatic renal cell cancer (mRCC) using integrated 18F-Fluorodeoxyglucose (18F-FDG) positron emission tomography/magnetic resonance imaging (PET/MRI); The REMAP study

The use of dual vacuum stabilization device to reduce kidney motion for stereotactic radiotherapy planning.

A comparison of radiologic tumor volume and pathologic tumor volume in renal cell carcinoma (RCC).

Short communication: timeline of radiation-induced kidney function loss after stereotactic ablative body radiotherapy of renal cell carcinoma as evaluated by serial (99m)Tc-DMSA SPECT/CT.

P304

e0202387

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0202387

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hayley M Reynolds

Eddie Lau

P577

2018-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30114235

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

6095575

http://www.w3.org/2001/XMLSchema#string